Note: Live price is not available for this stock. Showing closing price. For historical calculations, prices are adjusted for splits, bonus and rights issue. Percentage change shown is absolute irrespective of the period.
DCAL Stock Analysis
Views
Red Flags
Positive
Low Debt to Equity, not much change from last year
Company's earnings are of high quality
Negative
Expensive and at same valuation levels as industry median P/E
Low revenue growth and lower than median growth of industry
Low dividend yield
Neutral
Low ROE but improving trend
Low operating margin but improving trend
No red flags found!
No significant red flags found in the stock.
Snapshot
See detailed analysis
DCAL Shareholding Pattern
An overview of who owns the company. Click on chart icon to view historical movement.
DCAL Bulk, Block & Insider Trades
DCAL Dividends, Splits & Bonus
Dividend Events
Capital Change Events
No capital change events found
Company Profile
Dishman Carbogen Amcis Limited is engaged in offering contract research and manufacturing services (CRAMS) and the manufacture and supply of marketable molecules such as specialty chemicals, vitamins and chemicals, and disinfectants. Its segments include CRAMS and Marketable Molecules. The CRAMS seg... Read More
Key personnel
Mr. Harshil R. Dalal
Global Chief Financial Officer
Ms. Shrima Gaurangbhai Dave
Compliance Officer, Company Secretary
Mr. Arpit Janmejay VyasD
Global Managing Director, Executive Director
Mrs. Deohooti Janmejay VyasD
Whole-Time Director
Mr. Dhaval Rameshchandra ShahD
Non-Executive Non-Independent Director
Mr. Kulin Nalinkant ShahD
Independent Director
Mr. Hemantkumar Jayantiprasad Jayantiprasad BhattD
Non-Executive Independent Director
Ms. Margie Sunil ParikhD
Non-Executive Independent Director
View all
Incorporated on
Last Annual
Last Interim
No. of Employees
IPO date
Free Float
Website
Phone no.
Address
Frequently asked questions
What is the current share price of Dishman Carbogen Amcis Ltd.?
The current share price of Dishman Carbogen Amcis Ltd. is ₹ 257.74 as of 09 Jan 2026.
What is the PE ratio of Dishman Carbogen Amcis Ltd.?
The Price-to-Earnings (PE) ratio of Dishman Carbogen Amcis Ltd. is 29.63 as of the latest financial data.
What is the ROE and ROCE of Dishman Carbogen Amcis Ltd.?
Dishman Carbogen Amcis Ltd. has a Return on Equity (ROE) of 2.25% and a Return on Capital Employed (ROCE) of 3.10% as per the latest financial reports.
What is the market cap of Dishman Carbogen Amcis Ltd.?
The market capitalization of Dishman Carbogen Amcis Ltd. stands at ₹ 4,040.93 Cr.
What is the dividend yield of Dishman Carbogen Amcis Ltd.?
The dividend yield of Dishman Carbogen Amcis Ltd. is 0.00% based on the current market price.
What is the RSI of Dishman Carbogen Amcis Ltd.?
The Relative Strength Index (RSI) of Dishman Carbogen Amcis Ltd. is 56.36.
What is the FII and DII holding in Dishman Carbogen Amcis Ltd.?
Foreign Institutional Investors (FII) hold 8.07% and Domestic Institutional Investors (DII) hold 1.08% of Dishman Carbogen Amcis Ltd. shares.
What sector does Dishman Carbogen Amcis Ltd. belong to?
Dishman Carbogen Amcis Ltd. operates in the Healthcare sector.
What is the beta of Dishman Carbogen Amcis Ltd. stock?
The beta of Dishman Carbogen Amcis Ltd. stock is 1.71, indicating its volatility relative to the broader market.
